OCT-ISR
An educational app for OCT-ISR
Archived App (Last seen on 22 Nov 2025)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
An educational tool for cardiologists and technicians to understand Optical Coherence Tomography (OCT) in In-Stent Restenosis (ISR). It provides in-depth views of OCT images, classifications, and treatment information. Users can also submit their own OCT images.
What's New in OCT
1.0.15
May 19, 2021
- Added Dr. Garcia-Garcia to the Team
Developer apps
FAQ
What is OCT-ISR used for?
OCT-ISR is an educational app designed to help cardiologists and technicians understand Optical Coherence Tomography (OCT) in the context of In-Stent Restenosis (ISR). It provides detailed views of OCT images and classifications.
Is OCT-ISR free to use?
Yes, OCT-ISR is available for free. The app does not require any payment to download or use its educational features.
What devices does OCT-ISR support?
OCT-ISR is compatible with iPhone, iPad, and iPod devices. It is designed for use on Apple's mobile operating system.
How often is OCT-ISR updated?
The latest version of OCT-ISR is 1.0.15, which was last updated on May 19, 2021. Users can expect updates to improve functionality and content.
What is the age rating for OCT-ISR?
OCT-ISR has an age rating of 12+. This indicates it is suitable for users aged 12 and older.
Can I submit my own OCT images to OCT-ISR?
Yes, a feature within OCT-ISR allows users to submit their own OCT images. This can be a valuable tool for learning and sharing within the medical community.
Does OCT-ISR have ads?
No, OCT-ISR does not contain advertisements. The app is ad-free, allowing for an uninterrupted educational experience.
What kind of educational content does OCT-ISR offer?
OCT-ISR offers in-depth views of OCT images, educational content specifically for understanding in-stent restenosis, and information on available treatments for ISR.
